Showing results (481-490 of 686) with videos related to

Sort By:
Pageof 69
Cancer Research|September 1, 1987
Cytochrome P-450-mediated O-demethylation: a route in the metabolic activation of etoposide (VP-16-213)J M van Maanen, J de Vries, D Pappie, et al.
The Netherlands Journal of Medicine|December 1, 1989
Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesisC J van Groeningen, H E Gall, K A Simons, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patientsG Giaccone, E F Smit, J P van Meerbeeck, et al.
British Journal of Cancer|September 25, 1999
Potent interaction of flavopiridol with MRP1J H Hooijberg, H J Broxterman, G L Scheffer, et al.
British Journal of Haematology|February 13, 2001
The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimensF de Boer, A M Dräger, M J Van Haperen, et al.
British Journal of Cancer|March 5, 2002
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrugM de Graaf, E Boven, D Oosterhoff, et al.
Biochemical Pharmacology|February 5, 1999
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell linesC J van Moorsel, H M Pinedo, G Veerman, et al.
Nuclear Medicine and Biology|May 1, 1996
A facile method for the labeling of proteins with zirconium isotopesW E Meijs, H J Haisma, R Van der Schors, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated miceM Treskes, E Boven, A A van de Loosdrecht, et al.
Pageof 69